FI20010019A - Menetelmä atrofisen diagnostisoimiseksi - Google Patents

Menetelmä atrofisen diagnostisoimiseksi Download PDF

Info

Publication number
FI20010019A
FI20010019A FI20010019A FI20010019A FI20010019A FI 20010019 A FI20010019 A FI 20010019A FI 20010019 A FI20010019 A FI 20010019A FI 20010019 A FI20010019 A FI 20010019A FI 20010019 A FI20010019 A FI 20010019A
Authority
FI
Finland
Prior art keywords
diagnosis
procedure
atrophic gastritis
atrophic
gastritis
Prior art date
Application number
FI20010019A
Other languages
English (en)
Swedish (sv)
Other versions
FI20010019A0 (fi
Inventor
Osmo Suovaniemi
Matti Haerkoenen
Tapani Tiusanen
Pentti Sipponen
Original Assignee
Biohit Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oyj filed Critical Biohit Oyj
Priority to FI20010019A priority Critical patent/FI20010019A/fi
Publication of FI20010019A0 publication Critical patent/FI20010019A0/fi
Priority to CN028034953A priority patent/CN1484765B/zh
Priority to JP2002554731A priority patent/JP4348083B2/ja
Priority to US10/451,742 priority patent/US7358062B2/en
Priority to PCT/FI2002/000008 priority patent/WO2002054084A1/en
Priority to RU2003124185/15A priority patent/RU2262706C2/ru
Priority to EP02716100A priority patent/EP1348129A1/en
Publication of FI20010019A publication Critical patent/FI20010019A/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56922—Campylobacter
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/74—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving hormones or other non-cytokine intercellular protein regulatory factors such as growth factors, including receptors to hormones and growth factors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/595—Gastrins; Cholecystokinins [CCK]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96472—Aspartic endopeptidases (3.4.23)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/062—Gastritis or peptic ulcer disease
FI20010019A 2001-01-05 2001-01-05 Menetelmä atrofisen diagnostisoimiseksi FI20010019A (fi)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FI20010019A FI20010019A (fi) 2001-01-05 2001-01-05 Menetelmä atrofisen diagnostisoimiseksi
CN028034953A CN1484765B (zh) 2001-01-05 2002-01-04 一种用于诊断萎缩性胃炎的方法
JP2002554731A JP4348083B2 (ja) 2001-01-05 2002-01-04 萎縮性胃炎の検査方法
US10/451,742 US7358062B2 (en) 2001-01-05 2002-01-04 Method for diagnosing atrophic gastritis
PCT/FI2002/000008 WO2002054084A1 (en) 2001-01-05 2002-01-04 A method for diagnosing atrophic gastritis
RU2003124185/15A RU2262706C2 (ru) 2001-01-05 2002-01-04 Способ для диагностики атрофических гастритов
EP02716100A EP1348129A1 (en) 2001-01-05 2002-01-04 A method for diagnosing atrophic gastritis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FI20010019A FI20010019A (fi) 2001-01-05 2001-01-05 Menetelmä atrofisen diagnostisoimiseksi

Publications (2)

Publication Number Publication Date
FI20010019A0 FI20010019A0 (fi) 2001-01-05
FI20010019A true FI20010019A (fi) 2002-07-06

Family

ID=8559891

Family Applications (1)

Application Number Title Priority Date Filing Date
FI20010019A FI20010019A (fi) 2001-01-05 2001-01-05 Menetelmä atrofisen diagnostisoimiseksi

Country Status (7)

Country Link
US (1) US7358062B2 (fi)
EP (1) EP1348129A1 (fi)
JP (1) JP4348083B2 (fi)
CN (1) CN1484765B (fi)
FI (1) FI20010019A (fi)
RU (1) RU2262706C2 (fi)
WO (1) WO2002054084A1 (fi)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUE039881T2 (hu) 2002-05-09 2019-02-28 Brigham & Womens Hospital Inc 1L1RL-1, mint egy kardiovaszkuláris betegség-marker
FI119571B (fi) * 2002-09-06 2008-12-31 Biohit Oyj Menetelmä esofagiitin tai Barrettin ruokatorven riskin osoittamiseksi yksilöllä
JP4689597B2 (ja) * 2003-03-28 2011-05-25 レセプター バイオロジックス インク． ガストリンホルモン免疫アッセイ
FI119572B (fi) * 2004-03-05 2008-12-31 Biohit Oyj Menetelmä vatsan limakalvon tilan ennustamiseksi
ES2311895T3 (es) * 2004-03-15 2009-02-16 F. Hoffmann-La Roche Ag El uso de los peptidos tipo bnp y de los peptidos tipo anf para evaluar el riesgo de padecer una complicacion cardio-vascular como frecuencia de sobrecarga del volumen.
US20050272101A1 (en) * 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
CN101163971B (zh) * 2004-12-20 2013-03-20 免疫体公司 测定作为肾病诊断标记物的嗜中性粒细胞明胶酶相关性脂笼蛋白
US20070037232A1 (en) * 2005-03-31 2007-02-15 Barasch Jonathan M Detection of NGAL in chronic renal disease
US20080090304A1 (en) * 2006-10-13 2008-04-17 Barasch Jonathan Matthew Diagnosis and monitoring of chronic renal disease using ngal
AU2007263622B2 (en) * 2006-06-05 2013-05-30 Dysis Medical Limited Methods for characterizing tissues
JP2010500535A (ja) * 2006-08-07 2010-01-07 アンチボディショップ・アクティーゼルスカブ 重大な腎損傷を除外するための診断検査
US20080050749A1 (en) * 2006-08-17 2008-02-28 Ildiko Amann-Zalan Use of bnp-type peptides for the stratification of therapy with erythropoietic stimulating agents
FI20065542A0 (fi) * 2006-09-01 2006-09-01 Biohit Oyj Menetelmä ja näytteenottopakkaus vatsan limakalvon tilan arvioimiseksi
CN101910844A (zh) * 2007-10-26 2010-12-08 拜奥希特公司 用于诊断与萎缩性胃炎相联系的自身免疫性疾病和胃癌的方法和产品
PL2827152T3 (pl) 2008-04-18 2016-12-30 Rokowanie ryzyka głównych niekorzystnych zdarzeń sercowych
CN102227641B (zh) * 2008-10-01 2015-04-22 亚利桑那大学评议会 葡糖苷酸化的对乙酰氨基酚作为肝脏疾病的标志
WO2010118539A2 (en) * 2009-04-14 2010-10-21 Biocartis Sa Hifu induced cavitation with reduced power threshold
CN102087279A (zh) * 2010-03-11 2011-06-08 北京美康生物技术研究中心 一种联合诊断胃病或评价胃癌风险的酶联免疫吸附试剂盒
WO2011140093A2 (en) * 2010-05-03 2011-11-10 The Cleveland Clinic Foundation Detection and monitoring of nonalcoholic fatty liver disease
WO2011151783A1 (en) * 2010-05-31 2011-12-08 University Hospital Of Basel Method for assaying lower respiratory tract infection or inflammation
ES2372842B1 (es) * 2010-07-12 2013-08-13 Fundacion De La Comunidad Valenciana Centro De Investigacion Principe Felipe Método ex-vivo para el diagnóstico temprano de la encefalopatía hepática mínima mediante la determinación de 3-nitrotirosina en suero.
RU2465597C1 (ru) * 2011-04-08 2012-10-27 Сергей Михайлович Котелевец Способ определения вероятности развития рака желудка
CN111834009A (zh) 2012-08-21 2020-10-27 重症监护诊断股份有限公司 多标记风险分层
CN103914997B (zh) * 2014-04-02 2016-03-02 无锡宜偌维盛生物技术有限公司 一种胃功能演示仪
CN105242045A (zh) * 2014-06-13 2016-01-13 拜奥希特公司 胃泌素-17作为具有增加的数种相关后发病风险的萎缩性胃炎的生物标志物的用途
RU2560703C1 (ru) * 2014-09-17 2015-08-20 Федеральное государственное бюджетное учреждение "Научно-исследовательский институт молекулярной биологии и биофизики" Сибирского отделения Российской академии медицинских наук (ФГБУ "НИИМББ" СО РАМН) Способ выявления дисплазии эпителия слизистой оболочки желудка у пациентов с атрофическим гастритом или аденомой желудка
RU2584750C1 (ru) * 2015-05-22 2016-05-20 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт молекулярной биологии и биофизики" (НИИМББ) Способ выявления дисплазии эпителия слизистой оболочки желудка при ее атрофических изменениях
CN106198986A (zh) * 2016-08-31 2016-12-07 潍坊市康华生物技术有限公司 联合诊断胃病的化学发光检测试剂盒及其制备、使用方法
EP3296746A1 (en) * 2016-09-20 2018-03-21 Université de Bourgogne In vitro method for diagnosing at early stage intestinal ischemia
JP6885581B2 (ja) * 2017-02-06 2021-06-16 学校法人東京歯科大学 ガストリン測定におけるカットオフ値の推定方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4656025A (en) * 1985-04-19 1987-04-07 Emmanuel Deutsch Quantitative screening assay of tumor globulin from gastric juice
CA2117490C (en) * 1992-02-26 2009-01-06 Timothy L. Cover Purified vacuolating toxin from helicobacter pylori and methods to use same
FI97304C (fi) 1994-11-16 1996-11-25 Locus Genex Oy Menetelmä mahasyövän riskin seulonnaksi
CN1178523A (zh) * 1995-03-14 1998-04-08 第一制药株式会社 氨基酚衍生物
JP2949474B2 (ja) 1995-08-28 1999-09-13 隆久 古田 ペプシノーゲンｉ／ｉｉ比の変化率を基礎としたヘリコバクター・ピロリ除菌判定方法
US6852487B1 (en) * 1996-02-09 2005-02-08 Cornell Research Foundation, Inc. Detection of nucleic acid sequence differences using the ligase detection reaction with addressable arrays
FI118653B (fi) * 1999-04-30 2008-01-31 Biohit Oyj Menetelmä peptisen haavan riskin määrittämiseksi
FI990991A (fi) * 1999-04-30 2000-10-31 Locus Genex Oy Menetelmä irreversiibeleille neurovahingoille riskialttiin yksikön identifioimiseksi
US7179609B1 (en) * 2000-10-04 2007-02-20 Atrophus Ab Screening method for gastritis

Also Published As

Publication number Publication date
FI20010019A0 (fi) 2001-01-05
JP2004517322A (ja) 2004-06-10
WO2002054084A8 (en) 2003-01-30
JP4348083B2 (ja) 2009-10-21
US7358062B2 (en) 2008-04-15
CN1484765A (zh) 2004-03-24
EP1348129A1 (en) 2003-10-01
RU2003124185A (ru) 2005-01-10
RU2262706C2 (ru) 2005-10-20
US20040038376A1 (en) 2004-02-26
CN1484765B (zh) 2012-07-18
WO2002054084A1 (en) 2002-07-11

Similar Documents

Publication Publication Date Title
FI20010019A (fi) Menetelmä atrofisen diagnostisoimiseksi
NO20042680L (no) Fremgangsmater for fremstilling av O-demetylvenflaxine
NO20052580D0 (no) Blandinger for behandling av infeksjon av Flavivirida viruser
NO20033359L (no) Anvendelse av substituerte azetidinonforbindelser for behandling av sitosterolemi
NO20021474D0 (no) Forbindelser for behandling av ischemi
NO20043996L (no) Fremgangsmate for frembringelse av API'er
FI20031856A0 (fi) Menetelmä tietotallenteen eheyden varmistamiseksi
NO20022087D0 (no) Fremgangsmåte for behandling av diabetes
NO20045554L (no) Fremgangsmate for behandling av diabetes
NO20042667L (no) Fremgangsmate for fremstilling av escitalopram
ATE386742T1 (de) Imidazonaphthyridine
NO20034123L (no) Fremgangsmåte for behandling av brennstoff
NO20044814L (no) Fremgangsmate for fremstilling av combretastaniner
NO20033804D0 (no) Karbamatforbindelser for behandling av smerte
DE60325855D1 (de) Rifampicin zur Behandlung der Angiogenese
DE60140147D1 (de) Verzweigte organosilikonverbindung
ITGE20020050A0 (it) Procedimento per il trattamento di filati mediante agugliatura.
NO20024880D0 (no) Sammensetning inneholdende fosfat
DE10390373D2 (de) Phosphorchelatverbindungen
DE50202494D1 (de) Wellenabdichtung
NO20043113L (no) Fremgangsmate for behandling av benforstyrrelse
FI990781A0 (fi) Menetelmä lentotuhkan käsittelemiseksi
DE60220516D1 (de) Aromatase hemmung zur steigerung der implantationsrate
FI20010892A (fi) Menetelmä ksylitolin valmistamiseksi
NO20042542L (no) Anvendelse av ascomycin for behandling av blefarit

Legal Events

Date Code Title Description
FC Application refused